Sg Americas Securities, LLC Revance Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 76,963 shares of RVNC stock, worth $197,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,963
Holding current value
$197,794
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$2.57 - $2.57 $197,794 - $197,794
76,963 New
76,963 $399,000
Q4 2023

Jan 12, 2024
BUY
$5.81 - $11.2 $363,694 - $701,097
62,598 New
62,598 $550,000
Q1 2023

Apr 28, 2023
BUY
$18.36 - $35.27 $258,637 - $496,848
14,087 Added 188.78%
21,549 $694,000
Q4 2022

Feb 02, 2023
SELL
$18.32 - $30.66 $72,180 - $120,800
-3,940 Reduced 34.56%
7,462 $138,000
Q3 2022

Oct 31, 2022
BUY
$14.33 - $28.47 $163,390 - $324,614
11,402 New
11,402 $308,000
Q4 2021

Feb 07, 2022
SELL
$12.46 - $27.87 $423,154 - $946,493
-33,961 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$25.78 - $33.21 $685,180 - $882,655
26,578 Added 359.99%
33,961 $946,000
Q2 2021

Aug 12, 2021
SELL
$26.8 - $31.84 $177,148 - $210,462
-6,610 Reduced 47.24%
7,383 $219,000
Q1 2021

May 13, 2021
BUY
$24.03 - $29.97 $222,397 - $277,372
9,255 Added 195.34%
13,993 $391,000
Q4 2020

Feb 04, 2021
SELL
$23.41 - $28.34 $1.04 Million - $1.26 Million
-44,343 Reduced 90.35%
4,738 $134,000
Q3 2020

Nov 09, 2020
BUY
$23.23 - $34.3 $554,058 - $818,089
23,851 Added 94.53%
49,081 $1.23 Million
Q2 2020

Jul 20, 2020
BUY
$12.6 - $26.55 $193,536 - $407,808
15,360 Added 155.62%
25,230 $616,000
Q1 2020

Apr 30, 2020
BUY
$12.46 - $27.81 $24,222 - $54,062
1,944 Added 24.53%
9,870 $146,000
Q4 2019

Jan 28, 2020
BUY
$11.66 - $20.15 $92,417 - $159,708
7,926 New
7,926 $129,000
Q2 2019

Jul 29, 2019
SELL
$10.67 - $15.49 $117,167 - $170,095
-10,981 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$15.4 - $20.39 $169,107 - $223,902
10,981 New
10,981 $173,000
Q4 2017

Jan 24, 2018
SELL
$24.55 - $36.3 $128,421 - $189,885
-5,231 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$22.55 - $28.1 $117,959 - $146,991
5,231
5,231 $144,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email